Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 4Plasma cell 3Lymphoid 3Myeloid 2Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 19Myelodysplastic Syndromes 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Myeloproliferative Disorders 14Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Mantle-Cell 11Leukemia, Myelomonocytic, Chronic 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Hodgkin Disease 11Lymphoma, Non-Hodgkin 10Multiple Myeloma 9Leukemia, Myeloid, Chronic-Phase 9Lymphoma, Large B-Cell, Diffuse 8Waldenstrom Macroglobulinemia 7Myelodysplastic-Myeloproliferative Diseases 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Primary Myelofibrosis 6Leukemia, Prolymphocytic 6Leukemia, Biphenotypic, Acute 6Lymphoma 5Leukemia 5Burkitt Lymphoma 5Blast Crisis 5Anemia, Refractory, with Excess of Blasts 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Graft vs Host Disease 4Congenital Abnormalities 4Pdgfra-Associated Chronic Eosinophilic Leukemia 3Lymphoma, Large-Cell, Immunoblastic 3

Interventions

Cyclophosphamide 21fludarabine 20fludarabine phosphate 17Tacrolimus 12thymoglobulin 11Whole-Body Irradiation 11Busulfan 10Azacitidine 10Mycophenolic Acid 9Methotrexate 9Thiotepa 8Melphalan 8Antilymphocyte Serum 8venetoclax 7AP 1903 reagent 7Rituximab 6Sirolimus 5Imatinib Mesylate 5Granulocyte Colony-Stimulating Factor 5Cytarabine 5Cord Blood Stem Cell Transplantation 5merphos 4aldesleukin 4Peripheral Blood Stem Cell Transplantation 4Nivolumab 4Interleukin-2 4Dexamethasone 4enasidenib 3Tretinoin 3Stem Cell Transplantation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Cyclosporins × Myeloid × Clear all
NCT01231412 2026-04-30

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

Fred Hutchinson Cancer Center

Phase 3 Completed
174 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00075478 2017-05-15

Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Fred Hutchinson Cancer Center

Phase 3 Completed
87 enrolled 16 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Chronic-Phase, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡